JOSEPH SALEEB: Open Payments
NPI 1982624581 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 8 payments from 7 companies in 2025. Trend: 2023 $141 · 2024 $239 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 2 | $44 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: IBSRELA, TRELEGY ELLIPTA, KEVEYIS, HETLIOZ, CONTRAVE, Kerendia.
Industry payments across NJ — which companies pay providers there.
